Rivas-Verá S, Aguilar-Cortázar L, Mendoza-Galindo L, Alvarado-Miranda A, Arce-Salinas C

Language: Spanish
References: 19
Page: 18-22
PDF size: 315.91 Kb.

ABSTRACT

Primary breast lymphoma is an uncommon clinical entity that represents 0.05% of all breast tumors. Phenotypically, most of these neoplasias correspond to diffuse large B cells lymphomas and are associated with a poor prognostic. This paper presents a clinical case about a 69 years old woman that came to our Institution with a breast mass. Biopsy confirms the diagnosis of primary breast lymphoma; she was treated with 4 cycles of CHOP (cyclophosphamide, vincristine, doxorubicin and prednisone) and external radiotherapy. She has had a 4-year disease-free survival.

REFERENCES

1. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972; 29: 1705-1712.

2. Surov A, Holzhausen HJ, Wienke A, Schmidt J et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. B J Radiology. 2012; 85: e195-e205.

3. Sabate JM, Gomez A, Torruba S, Camins A, Roson N, De Las Heras P et al. Lymphoma of the breast: clinical and radiological features with pathologic correlation in 28 patients. Breast J. 2002; 8: 294-304.

4. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972; 29: 1705-1257.

5. Giardini R, Piccolo C, Rilike F. Primary non-Hodgkin’s lymphoma of the breast. Cancer. 1992; 69: 725-735.

6. Yeon Lyou Ch, Kyu Yang S, Hwan Choe D, Hee Lee B et al. Mammographic and sonographic findings of primary breast lymphoma. Clinical Imaging. 2007; 31: 234-238.

7. Surov A, Holzausen HG, Wienke A, Schmidt J et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. Br J Radiol. 2012; 85: e195-e205.

8. Sanguinetti A, Ragusa M, Lucchini R, Monacelli M, Calzolari F, Misso C et al. Primary breast lymphoma: case reports and review of the literature. G Chir. 2008; 29: 230-232.

9. Aviv A, Tadmor T, Polliack A. Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options. Ann Oncol. 2013; 24: 2236-2244.

10. Yan-Hui L, Fang-Ping Xu, Heng-Guo Z, Kin-Chung CL et al. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Human Pathology. 2008; 39: 875-884.

11. Li D, Jing-Deng MM, Hong HE MM et al. Primary breast diffuse large B-cell lymphoma shows B-cell like phenotype. Ann Diagnostic Pathology. 2012; 16: 335-343.

12. Niitsu N, Masataka O, Nakamine H, Hirano M. Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma. Leukemia Res. 2008; 32: 1837-1841.

13. Wong WW, Schild SE, Halyard MY, Schormberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol. 2002; 80: 19-25.

14. Vignot S, Ledoussal V, Nadiot Ph, Bourguignat A et al. Non-Hodgkin Lymphoma of the breast: a report of 19 cases and a review of the literature. Clinical Lymphoma. 2005; 6: 37-42.

15. Zhao S, Qing-Yuan Z, Wen-Jie M, Ming-Hui Z et al. Analysis of 31 cases of primary breast lymphoma: The effect of nodal involvement and microvascular density. Clinical Lymphoma Myeloma & Leukemia. 2011; 11: 33-37.

16. Bolat F, Kayaselcuk F, Nursal TZ et al. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J Exp Clin Cancer Res. 2006; 25: 365-372.

17. Tsutsui S, Yasuda K, Suzuki K et al. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep. 2005; 14: 425-431.

18. Chae Yeon L, Sang K, Du Hwan Ch, Byung Hee L et al. Mammographic and sonographic findigs of primary breast lymphoma. Clinical Imaging. 2007; 31: 234-238.

19. Ryan GF, Roos DR, Seymour JF. Primary non-Hodgkin’s lymphoma of the breast: retrospective analysis of prognosis and patterns of failure in two Australian centers. Clinical Lymphoma & Myeloma. 2006; 6: 337-341.